A clinical formulation indicated for Diabetes and Weight Loss. Consistent intake promotes efficient glucose regulation and facilitates natural appetite management.
A GLP-1 agonist formulated to manage blood sugar and intended to target weight loss in adults with obesity to support metabolic health.
Mechanism of Action
It mimics the GLP-1 hormone, which increases insulin secretion, slows stomach emptying, and reduces glucagon release. It also acts on brain centers to reduce hunger.
Route of Administration
Subcutaneous
Onset Time
Steady state in 4–5 weeks
Duration
1 week
Contraindications
Medullary thyroid cancer history, Multiple Endocrine Neoplasia type 2, Diabetic ketoacidosis
Information for Semaglutide is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.